Integrated analysis of single-cell and bulk RNA sequencing data reveals a pan-cancer stemness signature predicting immunotherapy response

Abstract Background Although immune checkpoint inhibitor (ICI) is regarded as a breakthrough in cancer therapy, only a limited fraction of patients benefit from it. Cancer stemness can be the potential culprit in ICI resistance, but direct clinical evidence is lacking. Methods Publicly available scR...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Zhen Zhang, Zi-Xian Wang, Yan-Xing Chen, Hao-Xiang Wu, Ling Yin, Qi Zhao, Hui-Yan Luo, Zhao-Lei Zeng, Miao-Zhen Qiu, Rui-Hua Xu
Formato: Artigo
Lenguaje:Inglês
Publicado: BMC 2022-04-01
Colección:Genome Medicine
Materias:
Big data analysis
Single-cell sequencing
Immune checkpoint therapy
Stemness
Pan-cancer
Acceso en línea:https://doi.org/10.1186/s13073-022-01050-w
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares